These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 3774117
1. Indoloquinolizidines, formal derivatives of tetrahydro-beta-carbolines, show selective affinity for benzodiazepine, tryptamine and serotonin binding sites in rat brain. Lounasmaa M, Saano V, Airaksinen MM, Jokela R, Huhtikangas A. Neuropharmacology; 1986 Aug; 25(8):915-8. PubMed ID: 3774117 [Abstract] [Full Text] [Related]
3. Tryptamine binding sites: potential site of action of tetrahydro-beta-carbolines. Kellar KJ, Cascio CS. Prog Clin Biol Res; 1982 Nov; 90():209-12. PubMed ID: 7111320 [No Abstract] [Full Text] [Related]
4. Stereoisomeric tetrahydro-beta-carbolines differ in their interaction with rat brain benzodiazepine receptors. Locock AR, Baker GB, Micetich RG, Coutts RT. Prog Neuropsychopharmacol Biol Psychiatry; 1983 Nov; 7(4-6):808-12. PubMed ID: 6320306 [Abstract] [Full Text] [Related]
5. Characterization and quantitative autoradiography of [3H]tryptamine binding sites in rat brain. Kaulen P, Brüning G, Rommelspacher H, Baumgarten HG. Brain Res; 1986 Feb 26; 366(1-2):72-88. PubMed ID: 3697697 [Abstract] [Full Text] [Related]
6. Binding of beta-carbolines and caffeine on benzodiazepine receptors: correlations to convulsions and tremor. Saano V, Airaksinen MM. Acta Pharmacol Toxicol (Copenh); 1982 Oct 26; 51(4):300-8. PubMed ID: 6295064 [Abstract] [Full Text] [Related]
7. Affinity of beta-carbolines on rat brain benzodiazepine and opiate binding sites. Airaksinen MM, Mikkonen E. Med Biol; 1980 Dec 26; 58(6):341-4. PubMed ID: 6112290 [Abstract] [Full Text] [Related]
8. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes. Komulainen H, Tuomisto J, Airaksinen MM, Kari I, Peura P, Pollari L. Acta Pharmacol Toxicol (Copenh); 1980 Apr 26; 46(4):299-307. PubMed ID: 7368949 [Abstract] [Full Text] [Related]
9. Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by beta-carbolines. Airaksinen MM, Lecklin A, Saano V, Tuomisto L, Gynther J. Pharmacol Toxicol; 1987 Jan 26; 60(1):5-8. PubMed ID: 3562389 [Abstract] [Full Text] [Related]
10. Heterogeneity of benzodiazepine receptors: experimental differences between [3H]flunitrazepam and [3H]ethyl-beta-carboline-3-carboxylate binding sites in rat brain membranes. Medina JH, Novas ML, De Robertis E. J Neurochem; 1983 Sep 26; 41(3):703-9. PubMed ID: 6135757 [No Abstract] [Full Text] [Related]
11. Pharmacology of harmalan (1-methyl-3,4-dihydro-beta-carboline). Rommelspacher H, Brüning G, Susilo R, Nick M, Hill R. Eur J Pharmacol; 1985 Mar 12; 109(3):363-71. PubMed ID: 2580722 [Abstract] [Full Text] [Related]
12. Characterization of [3H]tryptamine binding sites in brain. Cascio CS, Kellar KJ. Eur J Pharmacol; 1983 Nov 11; 95(1-2):31-9. PubMed ID: 6667714 [Abstract] [Full Text] [Related]